Search by Drug Name or NDC
NDC 72888-0123-00 Guanfacine 1 mg/1 Details
Guanfacine 1 mg/1
Guanfacine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Advagen Pharma Ltd. The primary component is GUANFACINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Guanfacine tablets (Tenex) are used alone or in combination with other medications to treat high blood pressure. Guanfacine extended-release (long-acting) tablets (Intuniv) are used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in children. Guanfacine is in a class of medications called centrally acting alpha2A-adrenergic receptor agonists. Guanfacine treats high blood pressure by decreasing heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Guanfacine extended-release tablets may treat ADHD by affecting the part of the brain that controls attention and impulsivity. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 72888-0123-00Last Updated: 05/26/2024
MedLinePlus Full Drug Details: Guanfacine
Product Information
| NDC | 72888-0123 |
|---|---|
| Product ID | 72888-123_085ebeaa-a0f4-b744-e063-6394a90a4d2f |
| Associated GPIs | |
| GCN Sequence Number | 000364 |
| GCN Sequence Number Description | guanfacine HCl TABLET 1 MG ORAL |
| HIC3 | A4B |
| HIC3 Description | ANTIHYPERTENSIVES, SYMPATHOLYTIC |
| GCN | 32480 |
| HICL Sequence Number | 000120 |
| HICL Sequence Number Description | GUANFACINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Guanfacine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guanfacine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUANFACINE HYDROCHLORIDE |
| Labeler Name | Advagen Pharma Ltd |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216762 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72888-0123-00 (72888012300)
| NDC Package Code | 72888-123-00 |
|---|---|
| Billing NDC | 72888012300 |
| Package | 1000 TABLET in 1 BOTTLE (72888-123-00) |
| Marketing Start Date | 2023-10-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |